SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications - Neurodegenerative

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: michael_f_murphy who started this subject1/23/2004 9:39:31 AM
From: nigel bates   of 448
 
Neuromolecular Inc.

Just parking - came across them when googling around memantine.

United States Patent 6,620,845
Wang ,   et al. September 16, 2003
------------------------------------------------------------------------
Aminoadamantane derivatives as therapeutic agents
Abstract

The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives and compositions. There are a variety of neurological disorders that can be treated using the present invention, including, for example, the following: neurological disorders arising from trauma, ischemic or hypoxic conditions that can be treated include stroke, hypoglycemia, cerebral ischemia, cardiac arrest, spinal cord trauma, head trauma, perinatal hypoxia, cardiac arrest and hypoglycemic neuronal damage; neurodegenerative disorders such as epilepsy, Alzheimer's disease, Huntington's disease Parkinsonism, and amyotrophic lateral sclerosis; other diseases or disorders such as convulsion, pain, depression, anxiety, schizophrenia, muscle spasms, migraine headaches, urinary incontinence, nicotine withdrawal, opiate tolerance and withdrawal, emesis, brain edema, tardive dyskinesia, AIDS-induced dementia, ocular damage, retinopathy, cognitive disorders, and neuronal injury associated with HIV-infection such as dysfunction in cognition, movement and sensation.
------------------------------------------------------------------------
Inventors: Wang; Yuqiang (Mountain View, CA); Ye; Wenqing (Fremont, CA); Larrick; James W. (Woodside, CA); Stemler; Jonathan S. (Chapel Hill, NC); Lipton; Stuart A. (Rancho Santa Fe, CA)
Assignee: NeuroMolecular, Inc. (Mill Valley, CA)
Appl. No.: 199156
Filed: July 19, 2002

Current U.S. Class: 514/511; 514/617; 514/619; 514/626; 514/629; 514/656; 514/662
Intern'l Class: A61K 031/21; A61K 031/165; A61K 031/16; A61K 031/135; A61K 031/13
Field of Search: 514/511,617,619,626,629,662,656
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext